Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

Cantey PT, Rout J, Rao G, Williamson J, Fox LM.

PLoS Negl Trop Dis. 2010 Jun 29;4(6):e728. doi: 10.1371/journal.pntd.0000728.

2.

Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.

Cantey PT, Rao G, Rout J, Fox LM.

Trop Med Int Health. 2010 Feb;15(2):224-31. doi: 10.1111/j.1365-3156.2009.02443.x.

4.

Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.

Adhikari RK, Sherchand JB, Mishra SR, Ranabhat K, Wagle RR.

J Community Health. 2015 Feb;40(1):34-40. doi: 10.1007/s10900-014-9891-1.

PMID:
24996654
5.

Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.

Abd Elaziz KM, El-Setouhy M, Bradley MH, Ramzy RM, Weil GJ.

Am J Trop Med Hyg. 2013 Aug;89(2):260-4. doi: 10.4269/ajtmh.12-0491.

6.

Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.

Sunish IP, Shriram AN, Sivan A, Kartick C, Saha BP, Vijayachari P.

Trop Doct. 2013 Jan;43(1):30-2. doi: 10.1177/0049475513482123.

PMID:
23550201
7.
8.
9.

Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala.

Aswathy S, Beteena K, Leelamoni K.

Ann Trop Med Parasitol. 2009 Oct;103(7):617-24. doi: 10.1179/000349809X12459740922255.

PMID:
19825283
10.

Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.

Babu BV, Babu GR.

Trans R Soc Trop Med Hyg. 2014 Sep;108(9):538-49. doi: 10.1093/trstmh/tru057. Review.

PMID:
24728444
11.
12.

The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.

Njomo DW, Amuyunzu-Nyamongo M, Magambo JK, Njenga SM.

PLoS One. 2012;7(11):e48395. doi: 10.1371/journal.pone.0048395.

13.

Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.

Sunish IP, Munirathinam A, Kalimuthu M, Ashok Kumar V, Tyagi BK.

J Trop Pediatr. 2014 Jun;60(3):245-8. doi: 10.1093/tropej/fmt101.

PMID:
24343822
14.

The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.

Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, Satyanarayana K.

Ann Trop Med Parasitol. 2002 Sep;96(6):595-602.

PMID:
12396322
15.

Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.

Ramaiah KD, Vanamail P, Yuvaraj J, Das PK.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):431-7. doi: 10.1016/j.trstmh.2011.04.006.

PMID:
21601901
16.

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

Rao RU, Nagodavithana KC, Samarasekera SD, Wijegunawardana AD, Premakumara WD, Perera SN, Settinayake S, Miller JP, Weil GJ.

PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3281. doi: 10.1371/journal.pntd.0003281. Erratum in: PLoS Negl Trop Dis. 2014 Dec;(12):e3428.

17.

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.

Kshirsagar NA, Gogtay NJ, Garg BS, Deshmukh PR, Rajgor DD, Kadam VS, Kirodian BG, Ingole NS, Mehendale AM, Fleckenstein L, Karbwang J, Lazdins-Helds JK.

Trans R Soc Trop Med Hyg. 2004 Apr;98(4):205-17. Erratum in: Trans R Soc Trop Med Hyg. 2004 May;98(5):329.

PMID:
15049459
18.

Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.

Sunish IP, Kalimuthu M, Rajendran R, Munirathinam A, Ashok Kumar V, Nagaraj J, Tyagi BK.

Parasitol Int. 2015 Feb;64(1):1-4. doi: 10.1016/j.parint.2014.08.005.

PMID:
25205435
19.

Improving community participation to eliminate lymphatic filariasis in American Samoa.

King JD, Zielinski-Gutierrez E, Pa'au M, Lammie P.

Acta Trop. 2011 Sep;120 Suppl 1:S48-54. doi: 10.1016/j.actatropica.2010.08.021.

20.

Endpoints for lymphatic filariasis programs.

Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ.

Emerg Infect Dis. 2007 Apr;13(4):608-10.

Supplemental Content

Support Center